Pace Diagnostics

Pace Diagnostics

Revolutionary point-of-care, affordable early detection Lung cancer and Tuberculosis diagnostics

Security Type
Min Investment
Los Angeles, CA
Offering Date
June 22, 2021
Expected Close Date
September 20, 2021

Company Description

Pace Diagnostics is an emerging biotechnology company focused on the research, development, licensing, manufacturing and marketing of cutting-edge diagnostics. Formed on the culmination of decades of basic and applied research, supported by grants and contracts from the US Federal Government.

Key Deal Facts

Raised $2.5 million in seed investment; Won > $6 million in grants from US DoD, NIH, and NSF
Huge market size: min 3.1 billion USD tuberculosis & 20 billion USD lung cancer diagnostics in 2022
British Biocell International (BBI) is our manufacturing partner
Each year: 10 million tuberculosis infections & 2 million deaths; 1 billion smokers & 2 million lung cancer deaths
Our TB test is specifically developed to meet all WHO requirements for performance, cost and use
Our products - low cost, accurate, non-invasive, non-lab dependent lung cancer & tuberculosis tests
We have a portfolio of proprietary material, filed patents and licensed IPs
Our products have clear path to FDA clinical trials & are targeted to have CE approval by early 2022

Management Team / Advisory Board Bios

Marianne Nguyen, Co-Founder
Mrs. Nguyen received her undergraduate and graduate training at Georgia Institute of Technology, UCI and UMass Amherst. She held senior leadership positions w/ Honeywell Safety Products, Ametek, Tyco and board member at various private ventures.

Lorne Matter, COO & Co-Founder
Mr. Mattner is an executive with a track record that includes building start up companies, both domestically and in Asia, fund raising and two successful exits. He earned his MBA and BS from the University of Southern California.

Hiep Hoa T Nguyen, President & Co-Founder
Dr. Nguyen is President & Chief Science Officer for several biotech companies that he co-founded. He received his BS in Chemistry & ChE, both summa cum laude. He received his PhD. in Chemistry/Biophysics from the California Institute of Technology.
Amount Raised : $0
Reveal the Score by Voting
Additional ratings from other users are needed to determine a viable CrowdScore for this deal.
The "CrowdScore" for this deal is determined by user ratings and other factors using our proprietary algorithm.
The overall viability and scalability of the business concept as well as the ability to drive the concept to profitability over time.
Business Idea
The progress made thus far in demonstrating that the business has viability, a customer base or other business traction.
Business Traction
The experience of the management team in running, scaling and/or exiting a business that required similar skills to execute the business plan.
Management Team
The value of the company compared to similar companies raising money from investors.

Security Description

A SAFE is an agreement between you—the investor—and the company in which the company promises to give you a future equity stake based on the amount you invested. It also involves some kind of a triggering event that must take place in order for you to get your future equity stake. Be careful as you may only get equity if a particular event is triggered.

Research Reports

No reports have been submitted

Become a Reporter